Basal Cell Carcinoma News and Research

RSS
Basal cell cancer begins in the lowest layer of the epidermis, the basal cell layer. About 8 out of 10 skin cancers are basal cell carcinomas. They usually begin on areas exposed to the sun, such as the head and neck. Basal cell carcinoma was once found mostly in middle-aged or older people. But now it is also being seen in younger people. This may be because people are spending more time in the sun without protecting their skin.

Basal cell carcinoma tends to grow slowly. It is very rare for a basal cell cancer to spread to distant parts of the body (metastasize). But if it is not treated, it can grow into nearby areas and spread into the bone or other tissues beneath the skin.

After treatment, basal cell carcinoma can come back (recur) in the same place on the skin. New basal cell cancers can also start in other places on the skin. As many as half of the people who have one basal cell cancer will get a new skin cancer within 5 years.
Scalable education program protects transplant survivors from elevated skin cancer risk

Scalable education program protects transplant survivors from elevated skin cancer risk

Case report details rare basal cell carcinoma on patient's finger

Case report details rare basal cell carcinoma on patient's finger

Melanoma disproportionately impacts Florida's senior population

Melanoma disproportionately impacts Florida's senior population

New AstroID database integrates clinical and genetic data for large-scale cancer studies

New AstroID database integrates clinical and genetic data for large-scale cancer studies

Common food preservatives may raise cancer risk

Common food preservatives may raise cancer risk

Early immunotherapy shows higher response in advanced basal cell carcinoma

Early immunotherapy shows higher response in advanced basal cell carcinoma

Next-generation imaging promises sharper, deeper view of living tissues

Next-generation imaging promises sharper, deeper view of living tissues

Scientists show for the first time how fibroblasts go 'rogue' in different diseases

Scientists show for the first time how fibroblasts go 'rogue' in different diseases

Study reveals early nicotinamide use reduces risk of aggressive skin cancers

Study reveals early nicotinamide use reduces risk of aggressive skin cancers

Simple AI model matches dermatologist expertise in assessing squamous cell carcinoma

Simple AI model matches dermatologist expertise in assessing squamous cell carcinoma

Electrophysiology-based strategies enhance cancer immunotherapy

Electrophysiology-based strategies enhance cancer immunotherapy

AI-powered dual-imaging approach enhances skin cancer detection accuracy

AI-powered dual-imaging approach enhances skin cancer detection accuracy

New data reveals insights into cancer and cardiovascular safety of JAK inhibitors

New data reveals insights into cancer and cardiovascular safety of JAK inhibitors

Cancer immunotherapy effective across all ages despite immune differences

Cancer immunotherapy effective across all ages despite immune differences

New 3D imaging technique enhances basal cell carcinoma diagnosis

New 3D imaging technique enhances basal cell carcinoma diagnosis

Examining skin cancer risk perceptions and reported sunburns among U.S. adults

Examining skin cancer risk perceptions and reported sunburns among U.S. adults

Cancer-fighting virus T-VEC helps shrink tough-to-treat skin tumors

Cancer-fighting virus T-VEC helps shrink tough-to-treat skin tumors

New therapy shows promise in treating basal cell carcinoma

New therapy shows promise in treating basal cell carcinoma

AI model enhances early detection of skin cancer with high accuracy

AI model enhances early detection of skin cancer with high accuracy

Study uncovers diversity of cancer-associated fibroblasts in skin cancer

Study uncovers diversity of cancer-associated fibroblasts in skin cancer

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.